| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| NM_000017.2 | .a | 1 to 1916 | 1 to 1916 | exact | RefSeq, AAA | 1916/1916 (100 %) | 0 diff (100 %id) | ||
| CD243966 | testis | .a | 20 to 807 | 29 to 823 | tiling clone, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 793/906 (87 %) | 32 diff (96.5 %id) | |
| CR747296 | brain, hippocampus | .a | 30 to 526 | 1 to 497 | 497/497 (100 %) | 2 diff (99.6 %id) | |||
| BX336141 | Placenta Cot 25-normalized | .a | 55 to 929 | 1 to 883 | 777/883 (87 %) | 16 diff (98.2 %id) | |||
| BM147901 | leukopheresis | .a | 58 to 437 | 1 to 380 | 380/380 (100 %) | 7 diff (98.2 %id) | |||
| TI_57217587 | .a | 64 to 899 | 66 to 903 | 836/903 (92 %) | 14 diff (98.5 %id) | ||||
| TI_57168417 | .a | 64 to 662 | 31 to 646 | 616/768 (80 %) | 32 diff (95.9 %id) | ||||
| BI754165 | brain | .a | 68 to 899 | 1 to 834 | 832/834 (99 %) | 8 diff (99.1 %id) | |||
| BI837314 | pooled pancreas and spleen | .a | 69 to 662 | 1 to 611 | 611/733 (83 %) | 33 diff (95.5 %id) | |||
| BI759476 | pooled colon, kidney, stomach | .a | 70 to 793 | 1 to 726 | 726/731 (99 %) | 8 diff (99.0 %id) | |||
| TI_57149480 | .a | 70 to 793 | 33 to 758 | 726/763 (95 %) | 14 diff (98.2 %id) | ||||
| CR596637 | Placenta Cot 25-normalized | .a | 71 to 1812 | 1 to 1742 | 1742/1742 (100 %) | 0 diff (100 %id) | |||
| BX397151 | Placenta Cot 25-normalized | .a | 71 to 1008 | 1 to 929 | fully sequenced, | 929/929 (100 %) | 13 diff (98.7 %id) | ||
| BG748176 | eye, normal pigmented retinal epithelium | .a | 71 to 883 | 1 to 816 | 816/816 (100 %) | 13 diff (98.5 %id) | |||
| BI826285 | brain, medulla | .a | 71 to 880 | 1 to 809 | 809/809 (100 %) | 6 diff (99.3 %id) | |||
| BI766581 | pooled lung and spleen | .a | 71 to 864 | 1 to 792 | 792/793 (99 %) | 7 diff (99.2 %id) | |||
| BI834549 | pooled pancreas and spleen | .a | 71 to 952 | 1 to 883 | 883/883 (100 %) | 21 diff (97.7 %id) | |||
| BM906375 | ovary (pool of 3) | .a | 71 to 910 | 12 to 859 | 848/1056 (80 %) | 18 diff (98.3 %id) | |||
| TI_57181560 | .a | 71 to 864 | 68 to 859 | 792/860 (92 %) | 13 diff (98.5 %id) | ||||
| TI_57173368 | .a | 71 to 880 | 62 to 870 | 809/870 (92 %) | 13 diff (98.6 %id) | ||||
| TI_57167730 | .a | 71 to 952 | 43 to 925 | 883/925 (95 %) | 30 diff (96.8 %id) | ||||
| BC025963 | Eye, normal, pigmented retinal epithelium | .a | 72 to 1916 | 1 to 1845 | tiling clone, available from MGC, AAA | 1845/1845 (100 %) | 5 diff (99.8 %id) | ||
| CR608104 | Neuroblastoma Cot 25-normalized | .a | 72 to 1889 | 1 to 1818 | 1818/1818 (100 %) | 0 diff (100 %id) | |||
| CR615642 | Placenta Cot 25-normalized | .a | 72 to 1882 | 1 to 1811 | 1811/1811 (100 %) | 0 diff (100 %id) | |||
| BX354551 | Neuroblastoma Cot 25-normalized | .a | 72 to 977 | 1 to 906 | fully sequenced, | 906/906 (100 %) | 9 diff (99.1 %id) | ||
| BX356023 | Placenta Cot 25-normalized | .a | 72 to 1082 | 1 to 1005 | fully sequenced, | 1005/1005 (100 %) | 8 diff (99.3 %id) | ||
| BQ723140 | sympathetic trunk | .a | 72 to 478 | 1 to 407 | 407/1144 (35 %) | 11 diff (99.1 %id) | |||
| AL522615 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 75 to 967 | 1 to 904 | 902/907 (99 %) | 40 diff (95.6 %id) | |||
| TI_57196525 | .a | 77 to 864 | 12 to 800 | 789/802 (98 %) | 13 diff (98.4 %id) | ||||
| BM911019 | astrocytoma grade IV, cell line, brain | .a | 79 to 588 | 1 to 510 | 510/1158 (44 %) | 20 diff (98.3 %id) | |||
| CR613518 | Neuroblastoma Cot 10-normalized | .a | 81 to 1897 | 1 to 1817 | 1817/1817 (100 %) | 0 diff (100 %id) | |||
| AL520693 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 81 to 969 | 1 to 889 | fully sequenced, | 889/889 (100 %) | 7 diff (99.3 %id) | ||
| CR600438 | Placenta Cot 25-normalized | .a | 82 to 1876 | 1 to 1795 | 1795/1795 (100 %) | 0 diff (100 %id) | |||
| CR607224 | Neuroblastoma Cot 25-normalized | .a | 82 to 1889 | 1 to 1808 | 1808/1808 (100 %) | 0 diff (100 %id) | |||
| BX379532 | Placenta Cot 25-normalized | .a | 82 to 1065 | 1 to 984 | 984/1063 (92 %) | 14 diff (98.7 %id) | |||
| BM906697 | ovary (pool of 3) | .a | 82 to 921 | 1 to 844 | 844/1139 (74 %) | 20 diff (98.3 %id) | |||
| TI_57173620 | .a | 82 to 867 | 58 to 847 | 790/847 (93 %) | 18 diff (97.9 %id) | ||||
| BX354793 | Neuroblastoma Cot 25-normalized | .a | 84 to 953 | 1 to 868 | fully sequenced, | 868/868 (100 %) | 8 diff (99.1 %id) | ||
| BX362020 | .a | 84 to 658 | 1 to 578 | 578/1071 (53 %) | 23 diff (97.9 %id) | ||||
| CR606773 | Neuroblastoma Cot 25-normalized | .a | 87 to 1904 | 1 to 1818 | tiling clone, | 1818/1818 (100 %) | 0 diff (100 %id) | ||
| BX394286 | Neuroblastoma Cot 25-normalized | .a | 87 to 1064 | 1 to 981 | 981/1045 (93 %) | 17 diff (98.4 %id) | |||
| BX401627 | .a | 87 to 429 | 1 to 345 | 345/995 (34 %) | 10 diff (99.0 %id) | ||||
| BI826419 | brain, medulla | .a | 87 to 867 | 1 to 784 | 784/784 (100 %) | 12 diff (98.5 %id) | |||
| TI_57235106 | .a | 87 to 589 | 25 to 537 | 513/845 (60 %) | 18 diff (97.9 %id) | ||||
| BM468073 | leiomyosarcoma, uterus | .a | 89 to 1048 | 1 to 975 | 975/1037 (94 %) | 26 diff (97.5 %id) | |||
| BM921057 | pooled brain, lung, testis | .a | 89 to 1053 | 11 to 989 | 979/990 (98 %) | 25 diff (97.5 %id) | |||
| TI_57152113 | .a | 89 to 795 | 97 to 832 | 678/835 (81 %) | 51 diff (93.9 %id) | ||||
| BI763608 | pooled colon, kidney, stomach | .a | 90 to 795 | 1 to 735 | 677/738 (91 %) | 46 diff (93.8 %id) | |||
| BU500283 | .a | 90 to 884 | 11 to 815 | 805/977 (82 %) | 20 diff (98.0 %id) | ||||
| DN996976 | breast cancer, Mammary gland (cancer tissue) | .a | 90 to 798 | 1 to 709 | 709/709 (100 %) | 4 diff (99.5 %id) | |||
| CN481223 | eye | .a | 91 to 686 | 1 to 596 | 596/596 (100 %) | 11 diff (98.2 %id) | |||
| BG170839 | hypernephroma, cell line, Kidney | .a | 91 to 881 | 1 to 780 | 780/784 (99 %) | 28 diff (96.5 %id) | |||
| BU186480 | large cell carcinoma, lung | .a | 91 to 586 | 1 to 501 | 501/920 (54 %) | 19 diff (98.0 %id) | |||
| BU599884 | mixed (pool of 40 RNAs) | .a | 91 to 670 | 1 to 584 | 584/689 (84 %) | 10 diff (98.6 %id) | |||
| AW207366 | .a | 92 to 233 | 169 to 28 | AAA | 142/152 (93 %) | 6 diff (96.1 %id) | |||
| BI908222 | leukocyte | .a | 92 to 589 | 1 to 508 | 508/816 (62 %) | 13 diff (98.5 %id) | |||
| DB463398 | hippocampus | .a | 93 to 530 | 1 to 435 | 435/435 (100 %) | 5 diff (98.9 %id) | |||
| DB463929 | hippocampus | .a | 93 to 478 | 1 to 387 | 387/415 (93 %) | 14 diff (96.7 %id) | |||
| DB106580 | thymus | .a | 94 to 655 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
| BI819047 | pooled brain, lung, testis | .a | 96 to 864 | 1 to 770 | 770/772 (99 %) | 8 diff (99.0 %id) | |||
| BM907049 | brain, hippocampus | .a | 96 to 740 | 1 to 649 | 649/1161 (55 %) | 25 diff (97.9 %id) | |||
| M26393 | .a | 96 to 1916 | 10 to 1829 | 1820/1829 (99 %) | 7 diff (99.7 %id) | ||||
| BM824740 | Ascites, stomach | .a | 99 to 580 | 1 to 482 | 482/482 (100 %) | 2 diff (99.6 %id) | |||
| BI760300 | pooled colon, kidney, stomach | .a | 103 to 742 | 1 to 663 | 663/812 (81 %) | 31 diff (96.2 %id) | |||
| TI_57148227 | .a | 103 to 742 | 35 to 697 | 662/846 (78 %) | 35 diff (95.9 %id) | ||||
| BQ954159 | leiomyosarcoma, uterus | .a | 104 to 897 | 1 to 806 | 806/893 (90 %) | 21 diff (97.7 %id) | |||
| BM923843 | pooled colon, kidney, stomach | .a | 109 to 1064 | 1 to 951 | 951/1002 (94 %) | 12 diff (98.9 %id) | |||
| TI_57146525 | .a | 109 to 1027 | 38 to 961 | 924/963 (95 %) | 34 diff (96.5 %id) | ||||
| BI764033 | pooled colon, kidney, stomach | .a | 110 to 1027 | 1 to 923 | 923/925 (99 %) | 29 diff (96.9 %id) | |||
| CR604877 | Neuroblastoma Cot 25-normalized | .a | 116 to 1867 | 1 to 1752 | 1752/1752 (100 %) | 0 diff (100 %id) | |||
| AL524457 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 116 to 1057 | 1 to 934 | 934/1006 (92 %) | 19 diff (98.2 %id) | |||
| TI_1948218010 | .a | 118 to 773 | 138 to 793 | fully sequenced, | 656/793 (82 %) | 8 diff (99.0 %id) | |||
| TI_1948218174 | .a | 118 to 742 | 135 to 759 | 625/1264 (49 %) | 8 diff (99.4 %id) | ||||
| TI_1948218346 | .a | 118 to 680 | 133 to 695 | fully sequenced, | 563/695 (81 %) | 8 diff (98.9 %id) | |||
| TI_1948218516 | .a | 118 to 811 | 139 to 843 | fully sequenced, | 705/843 (83 %) | 13 diff (98.5 %id) | |||
| AB527081 | .a | 119 to 1357 | 1 to 1239 | 1239/1239 (100 %) | 1 diff (100.0 %id) | ||||
| EL735312 | mixed | .a | 119 to 946 | 1 to 828 | 828/828 (100 %) | 2 diff (99.8 %id) | |||
| CR749004 | pooled colon, kidney, stomach | .a | 120 to 620 | 1 to 501 | 501/501 (100 %) | 1 diff (99.9 %id) | |||
| BG760267 | melanotic melanoma, high MDR (cell line), skin | .a | 122 to 1027 | 1 to 898 | 900/903 (99 %) | 18 diff (98.1 %id) | |||
| BM925520 | brain | .a | 127 to 1053 | 14 to 949 | 936/1071 (87 %) | 30 diff (97.2 %id) | |||
| BI758261 | brain | .a | 147 to 1008 | 33 to 890 | 858/899 (95 %) | 40 diff (95.6 %id) | |||
| TI_57220854 | .a | 147 to 1008 | 92 to 949 | 858/958 (89 %) | 40 diff (95.9 %id) | ||||
| BQ326233 | colon_normal | .a | 243 to 771 | 1 to 533 | 533/533 (100 %) | 25 diff (95.4 %id) | |||
| BE870887 | adenocarcinoma, colon | .a | 264 to 931 | 1 to 670 | 670/787 (85 %) | 33 diff (95.9 %id) | |||
| BE010816 | breast_normal | .a | 272 to 453 | 10 to 191 | 182/191 (95 %) | 7 diff (96.4 %id) | |||
| BQ326230 | colon_normal | .a | 291 to 768 | 6 to 488 | 481/488 (98 %) | 29 diff (94.1 %id) | |||
| BM927691 | hepatocellular carcinoma, cell line, Liver | .a | 371 to 1378 | 1 to 1018 | 1018/1021 (99 %) | 25 diff (97.6 %id) | |||
| BM790424 | Ascites, stomach | .a | 483 to 1087 | 1 to 605 | 605/605 (100 %) | 0 diff (100 %id) | |||
| BM794210 | Ascites, stomach | .a | 483 to 1123 | 1 to 642 | 642/642 (100 %) | 3 diff (99.6 %id) | |||
| CX756047 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 502 to 1209 | 1 to 698 | Submitted on the opposite strand | 698/750 (93 %) | 10 diff (98.7 %id) | ||
| CD607143 | .a | 544 to 1246 | 1 to 696 | 696/696 (100 %) | 10 diff (98.6 %id) | ||||
| TI_1948218347 | .a | 650 to 1356 | 830 to 124 | fully sequenced, | 707/830 (85 %) | 3 diff (99.7 %id) | |||
| BM791524 | Ascites, stomach | .a | 671 to 1298 | 1 to 628 | 628/628 (100 %) | 1 diff (99.9 %id) | |||
| TI_1948218011 | .a | 712 to 1356 | 771 to 126 | fully sequenced, | 646/771 (83 %) | 2 diff (99.8 %id) | |||
| TI_1948218175 | .a | 741 to 1356 | 741 to 126 | 616/1195 (51 %) | 2 diff (99.9 %id) | ||||
| CN396220 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 774 to 1427 | 1 to 651 | 651/651 (100 %) | 3 diff (99.6 %id) | |||
| TI_1948218517 | .a | 781 to 1356 | 701 to 123 | fully sequenced, | 579/701 (82 %) | 4 diff (99.5 %id) | |||
| BG259621 | embryonal carcinoma, cell line, testis | .a | 782 to 1435 | 1 to 653 | 653/653 (100 %) | 4 diff (99.4 %id) | |||
| BE879577 | large cell carcinoma, undifferentiated, lung | .a | 805 to 1412 | 1 to 603 | 603/612 (98 %) | 12 diff (98.1 %id) | |||
| BG489857 | large cell carcinoma, lung | .a | 838 to 1602 | 1 to 763 | 763/764 (99 %) | 13 diff (98.3 %id) | |||
| CD607144 | .a | 895 to 1598 | 710 to 9 | 702/710 (98 %) | 1 diff (99.9 %id) | ||||
| EC448869 | Prostate | .a | 916 to 999 | 1 to 83 | 83/83 (100 %) | 1 diff (98.8 %id) | |||
| TI_149293491 | .a | 916 to 1916 | 1075 to 85 | AAA | 925/998 (92 %) | 14 diff (98.6 %id) | |||
| AL579732 | T cells from T cell leukemia | .a | 918 to 1317 | 811 to 425 | 387/818 (47 %) | 13 diff (98.5 %id) | |||
| BX354792 | Neuroblastoma Cot 25-normalized | .a | 923 to 1889 | 964 to 1 | fully sequenced, | 964/964 (100 %) | 9 diff (99.1 %id) | ||
| CF453781 | peripheral nervous system | .a | 925 to 1626 | 1 to 702 | 702/702 (100 %) | 5 diff (99.3 %id) | |||
| H65932 | liver and spleen | .a | 930 to 1229 | 15 to 310 | 296/310 (95 %) | 10 diff (96.8 %id) | |||
| AL561902 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 939 to 1897 | 956 to 1 | fully sequenced, | 956/956 (100 %) | 6 diff (99.4 %id) | ||
| BX354550 | Neuroblastoma Cot 25-normalized | .a | 947 to 1889 | 934 to 1 | fully sequenced, | 934/934 (100 %) | 13 diff (98.7 %id) | ||
| BX336140 | Placenta Cot 25-normalized | .a | 960 to 1883 | 927 to 1 | 927/927 (100 %) | 6 diff (99.4 %id) | |||
| AL562113 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 975 to 1694 | 962 to 237 | 726/962 (75 %) | 3 diff (99.7 %id) | |||
| BX397150 | Placenta Cot 25-normalized | .a | 978 to 1812 | 831 to 1 | fully sequenced, | 831/831 (100 %) | 11 diff (98.7 %id) | ||
| N57178 | placenta | .a | 981 to 1078 | 1 to 98 | 98/98 (100 %) | 1 diff (99.0 %id) | |||
| BQ894554 | Spleen | .a | 1001 to 1694 | 1 to 715 | 715/960 (74 %) | 29 diff (97.0 %id) | |||
| BE869341 | adenocarcinoma, colon | .a | 1004 to 1412 | 1 to 409 | 409/409 (100 %) | 0 diff (100 %id) | |||
| BM789010 | Ascites, stomach | .a | 1015 to 1466 | 1 to 452 | 452/452 (100 %) | 1 diff (99.8 %id) | |||
| BM796972 | Ascites, stomach | .a | 1032 to 1419 | 1 to 389 | 389/389 (100 %) | 3 diff (99.3 %id) | |||
| AL562351 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1049 to 1853 | 826 to 16 | 811/1081 (75 %) | 11 diff (99.0 %id) | |||
| BX394285 | Neuroblastoma Cot 25-normalized | .a | 1049 to 1889 | 857 to 17 | 841/1107 (75 %) | 0 diff (100 %id) | |||
| BX356022 | Placenta Cot 25-normalized | .a | 1049 to 1882 | 833 to 1 | fully sequenced, | 833/833 (100 %) | 5 diff (99.4 %id) | ||
| BX379531 | Placenta Cot 25-normalized | .a | 1049 to 1804 | 828 to 73 | 756/1023 (73 %) | 1 diff (100.0 %id) | |||
| CN396219 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1087 to 1544 | 1 to 459 | 459/459 (100 %) | 2 diff (99.6 %id) | |||
| BU539840 | adenocarcinoma, cell line, breast | .a | 1132 to 1803 | 1 to 672 | 672/904 (74 %) | 7 diff (99.3 %id) | |||
| BU537975 | adenocarcinoma, cell line, breast | .a | 1134 to 1916 | 1 to 790 | 790/957 (82 %) | 46 diff (95.2 %id) | |||
| TI_149287394 | .a | 1145 to 1916 | 829 to 61 | AAA | 769/1093 (70 %) | 11 diff (99.0 %id) | |||
| BM700560 | eye, lens | .a | 1146 to 1376 | 1 to 231 | fully sequenced, | 231/231 (100 %) | 0 diff (100 %id) | ||
| BM819381 | stomach | .a | 1157 to 1727 | 1 to 572 | 572/572 (100 %) | 5 diff (99.2 %id) | |||
| CA307161 | Alveolar Macrophage, lung | .a | 1183 to 1916 | 752 to 19 | AAA | 734/734 (100 %) | 3 diff (99.6 %id) | ||
| BU682624 | lung | .a | 1187 to 1916 | 747 to 19 | AAA | 729/729 (100 %) | 1 diff (99.9 %id) | ||
| AI494471 | B-cell, chronic lymphotic leukemia | .a | 1202 to 1916 | 728 to 14 | AAA | 715/843 (84 %) | 24 diff (97.2 %id) | ||
| AI817034 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .a | 1202 to 1915 | 713 to 1 | 713/747 (95 %) | 27 diff (96.4 %id) | |||
| AA621716 | .a | 1226 to 1916 | 698 to 16 | AAA | 683/683 (100 %) | 32 diff (95.4 %id) | |||
| AA621782 | .a | 1248 to 1917 | 673 to 5 | 669/673 (99 %) | 0 diff (100 %id) | ||||
| BQ448199 | Knee, Osteoarthritic Cartilage | .a | 1291 to 1916 | 644 to 19 | AAA | 626/626 (100 %) | 0 diff (100 %id) | ||
| BM992144 | Bone, Subchondral Bone | .a | 1292 to 1916 | 643 to 19 | AAA | 625/625 (100 %) | 2 diff (99.7 %id) | ||
| AI417924 | Prostate | .a | 1305 to 1916 | 620 to 17 | AAA | 604/604 (100 %) | 15 diff (97.6 %id) | ||
| BM972720 | lung | .a | 1337 to 1916 | 597 to 19 | AAA | 579/579 (100 %) | 3 diff (99.5 %id) | ||
| BU737787 | eye, lens | .a | 1346 to 1916 | 589 to 19 | fully sequenced, AAA | 571/571 (100 %) | 2 diff (99.7 %id) | ||
| AA535132 | colon | .a | 1379 to 1914 | 537 to 1 | 537/537 (100 %) | 15 diff (97.3 %id) | |||
| CA430949 | cell lines, Chondrosarcoma | .a | 1388 to 1916 | 547 to 19 | AAA | 529/529 (100 %) | 0 diff (100 %id) | ||
| BU620554 | cell lines, Chondrosarcoma | .a | 1389 to 1916 | 548 to 19 | AAA | 530/530 (100 %) | 3 diff (99.5 %id) | ||
| AA947312 | 2 pooled tumors (clear cell type), Kidney | .a | 1395 to 1917 | 529 to 6 | 524/529 (99 %) | 0 diff (100 %id) | |||
| AI961011 | pooled germ cell tumors | .a | 1395 to 1916 | 522 to 1 | 522/522 (100 %) | 3 diff (99.5 %id) | |||
| AW264915 | lung, two pooled squamous cell carcinomas | .a | 1396 to 1916 | 537 to 18 | AAA | 520/524 (99 %) | 7 diff (98.7 %id) | ||
| AA777408 | liver and spleen | .a | 1403 to 1916 | 514 to 1 | 514/514 (100 %) | 33 diff (93.6 %id) | |||
| AW105320 | ovary, tumor, 5 pooled (see description) | .a | 1407 to 1916 | 536 to 27 | AAA | 510/554 (92 %) | 26 diff (95.4 %id) | ||
| AW469721 | pooled | .a | 1410 to 1917 | 515 to 8 | 508/518 (98 %) | 0 diff (100 %id) | |||
| AI445323 | colon, moderately-differentiated adenocarcinoma | .a | 1413 to 1916 | 523 to 22 | AAA | 502/506 (99 %) | 16 diff (96.9 %id) | ||
| AA676663 | whole brain | .a | 1416 to 1916 | 502 to 3 | 500/502 (99 %) | 0 diff (100 %id) | |||
| CA309938 | Alveolar Macrophage, lung | .a | 1416 to 1916 | 519 to 19 | AAA | 501/501 (100 %) | 2 diff (99.7 %id) | ||
| AI554875 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1422 to 1916 | 495 to 1 | 495/495 (100 %) | 3 diff (99.4 %id) | |||
| AA636131 | invasive tumor (cell line), Prostate | .a | 1430 to 1917 | 484 to 1 | 484/484 (100 %) | 18 diff (96.3 %id) | |||
| AW206349 | .a | 1436 to 1916 | 498 to 18 | AAA | 481/481 (100 %) | 2 diff (99.6 %id) | |||
| DB576489 | hypothalamus | .a | 1453 to 1916 | 1 to 464 | Submitted on the opposite strand | 464/464 (100 %) | 2 diff (99.6 %id) | ||
| R76645 | breast | .a | 1454 to 1505 | 1 to 52 | 52/52 (100 %) | 2 diff (96.2 %id) | |||
| AJ572173 | pectoral muscle (after mastectomy) | .a | 1462 to 1915 | 1 to 453 | 453/453 (100 %) | 4 diff (99.2 %id) | |||
| AI672807 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .a | 1463 to 1916 | 466 to 16 | AAA | 451/459 (98 %) | 6 diff (98.7 %id) | ||
| DB529266 | hippocampus | .a | 1464 to 1916 | 1 to 451 | Submitted on the opposite strand | 451/451 (100 %) | 5 diff (98.9 %id) | ||
| AI619926 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 1466 to 1916 | 461 to 14 | AAA | 448/448 (100 %) | 25 diff (94.5 %id) | ||
| AI953427 | normal epithelium, ovary | .a | 1468 to 1917 | 450 to 1 | 450/450 (100 %) | 0 diff (100 %id) | |||
| AI344455 | 2 pooled tumors (clear cell type), Kidney | .a | 1472 to 1917 | 449 to 4 | 446/449 (99 %) | 0 diff (100 %id) | |||
| H65845 | liver and spleen | .a | 1474 to 1914 | 444 to 1 | 444/446 (99 %) | 26 diff (94.2 %id) | |||
| BM145139 | leukopheresis | .a | 1477 to 1916 | 456 to 18 | 439/456 (96 %) | 0 diff (100 %id) | |||
| DB556524 | hypothalamus | .a | 1487 to 1909 | 1 to 419 | Submitted on the opposite strand | 419/426 (98 %) | 7 diff (98.4 %id) | ||
| F25645 | pectoral muscle (after mastectomy) | .a | 1492 to 1917 | 1 to 427 | 427/430 (99 %) | 3 diff (99.4 %id) | |||
| AI418089 | Prostate | .a | 1497 to 1916 | 417 to 1 | 417/417 (100 %) | 9 diff (97.9 %id) | |||
| AA580430 | colon, colon tumor | .a | 1500 to 1916 | 428 to 13 | AAA | 416/482 (86 %) | 39 diff (92.0 %id) | ||
| F28633 | pectoral muscle (after mastectomy) | .a | 1503 to 1713 | 1 to 210 | 210/210 (100 %) | 2 diff (99.1 %id) | |||
| BX401626 | .a | 1525 to 1862 | 361 to 23 | 339/1082 (31 %) | 0 diff (100 %id) | ||||
| BM707599 | eye, RPE and Choroid | .a | 1529 to 1916 | 1 to 388 | fully sequenced, | 388/388 (100 %) | 1 diff (99.8 %id) | ||
| N29759 | placenta | .a | 1537 to 1917 | 385 to 2 | 384/393 (97 %) | 0 diff (100 %id) | |||
| AI942343 | Kidney | .a | 1542 to 1916 | 392 to 20 | AAA | 373/373 (100 %) | 10 diff (97.4 %id) | ||
| CD240150 | .a | 1559 to 1895 | 48 to 391 | 344/391 (87 %) | 6 diff (98.5 %id) | ||||
| R76570 | breast | .a | 1573 to 1903 | 341 to 12 | 330/349 (94 %) | 0 diff (100 %id) | |||
| AA730535 | Ewing's sarcoma | .a | 1575 to 1916 | 1 to 338 | 338/338 (100 %) | 14 diff (95.9 %id) | |||
| AJ574100 | pectoral muscle (after mastectomy) | .a | 1620 to 1913 | 1 to 274 | 274/274 (100 %) | 20 diff (92.8 %id) | |||
| BU733158 | eye, RPE and Choroid | .a | 1632 to 1916 | 303 to 19 | fully sequenced, AAA | 285/285 (100 %) | 1 diff (99.7 %id) | ||
| AA643866 | normal prostate, Prostate | .a | 1633 to 1782 | 150 to 1 | 150/150 (100 %) | 2 diff (98.7 %id) | |||
| AJ573426 | pectoral muscle (after mastectomy) | .a | 1639 to 1899 | 1 to 260 | 260/260 (100 %) | 7 diff (97.4 %id) | |||
| AJ574598 | pectoral muscle (after mastectomy) | .a | 1657 to 1917 | 1 to 257 | 257/263 (97 %) | 10 diff (96.2 %id) | |||
| BE502395 | pooled germ cell tumors | .a | 1718 to 1917 | 203 to 4 | 200/203 (98 %) | 0 diff (100 %id) | |||
| AL557983 | T cells from T cell leukemia | .b | 1 to 728 | 1 to 728 | tiling clone, fully sequenced, | 728/728 (100 %) | 0 diff (100 %id) | ||
| AL579910 | T cells from T cell leukemia | .b | 667 to 1438 | 774 to 1 | tiling clone, fully sequenced, | 774/774 (100 %) | 6 diff (99.3 %id) | ||
| CR613358 | T cells (Jurkat cell line) Cot10-normalized | .c | 1 to 1437 | 1 to 1437 | exact | tiling clone, | 1437/1437 (100 %) | 0 diff (100 %id) | |
| R73351 | breast | .d | 1 to 391 | 61 to 467 | tiling clone, | 407/469 (86 %) | 35 diff (92.6 %id) | ||
| R72877 | breast | .d | 1210 to 1458 | 249 to 1 | tiling clone, | 249/249 (100 %) | 10 diff (96.0 %id) | ||
| BM921277 | pooled brain, lung, testis | .e | -11 to 838 | 1 to 853 | E256G P257A G258R M259E G260W ... | tiling clone, | 853/1045 (81 %) | 16 diff (98.5 %id) | |
| DB487184 | hypothalamus | .f | 1 to 439 | 1 to 438 | tiling clone, | 438/438 (100 %) | 4 diff (99.1 %id) | ||
| DB505221 | hypothalamus | .f | 1 to 452 | 1 to 452 | 452/452 (100 %) | 3 diff (99.4 %id) | |||
| BI919091 | brain | .f | 34 to 769 | 10 to 755 | 746/755 (98 %) | 23 diff (97.0 %id) | |||
| TI_57242014 | .f | 34 to 769 | 10 to 755 | 746/755 (98 %) | 23 diff (97.0 %id) | ||||
| BX398616 | Placenta Cot 25-normalized | .f | 71 to 1181 | 1 to 1097 | tiling clone, to resequence, | 1097/1098 (99 %) | 25 diff (97.8 %id) | ||
| DA383775 | thalamus | .f | 98 to 705 | 2 to 609 | capped | 608/608 (100 %) | 3 diff (99.6 %id) | ||
| BI770149 | pooled lung and spleen | .f | 134 to 886 | 1 to 753 | tiling clone, | 753/753 (100 %) | 0 diff (100 %id) | ||
| TI_57178205 | .f | 134 to 886 | 34 to 786 | 753/786 (95 %) | 6 diff (99.3 %id) | ||||
| BX398615 | Placenta Cot 25-normalized | .f | 1464 to 2432 | 985 to 1 | tiling clone, to resequence, | 856/985 (86 %) | 33 diff (96.7 %id) | ||
| DC385409 | rectum | .g | 1 to 548 | 2 to 549 | exact | tiling clone, | 549/549 (100 %) | 4 diff (99.3 %id) | |
| AK300645 | rectum | Gene ACADS, variant not shown | Suspected internal deletion, this clone was ignored |
| ? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f, .g | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DC |